D-dimer and C-reactive Protein Blood Levels Over Time Used to Predict Pulmonary Embolism in Two COVID-19 Patients

European Journal of Case Reports in Internal Medicine

Irina Gringauz¹  Leonid Goldman¹  Dan Justo²  Nadav Schacham²  Yael Becher² 

[1] Aff. to Sackler School of Medicine, Tel-Aviv University, Israel;Geriatrics and Internal Medicine B Department, Sheba Medical Center, Ramat-Gan, Israel;

关键词: covid-19;    c-reactive protein;    d-dimer;    pulmonary embolism;   

DOI  :  10.12890/2020_001725

来源: DOAJ

【 摘 要 】

The diagnosis of pulmonary embolism is challenging in symptomatic COVID-19 patients since shortness of breath, chest pain, tachycardia, tachypnoea, fever, oxygen desaturation and high D-dimer blood levels might be features of both diseases. We present two COVID-19 patients in whom pulmonary embolism was suspected (and diagnosed) due to a discrepancy between an increase in D-dimer blood levels and a decrease in C-reactive protein blood levels over time. We believe that an opposite change in the blood levels of both biomarkers over time may be used as a novel method to predict pulmonary embolism in COVID-19 patients.

【 授权许可】

Unknown